Importantly, in a recent prospective study by Ciangura et al., the authors divided participants diagnosed with GCK-MODY into two groups in which the initiation of insulin therapy was decided based on measurements of (1) maternal capillary blood glucose (MG) or (2) fetal abdominal circumference by ultrasound (FG) [21]. Here, INS is linked to MODY.